» Articles » PMID: 12601420

The Use of Complementary/alternative Medicine by Cancer Patients in a New Zealand Regional Cancer Treatment Centre

Overview
Journal N Z Med J
Specialty General Medicine
Date 2003 Feb 26
PMID 12601420
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To study the prevalence and patterns of complementary/alternative medicine (CAM) use in cancer patients managed by a New Zealand regional cancer treatment centre.

Methods: A self-administered anonymous questionnaire was used to survey patients attending outpatient clinics of the MidCentral Regional Cancer Treatment Service. Questions addressed patient demographics, cancer diagnosis and conventional treatments received. CAM users were asked to identify types of therapies used, reasons for use, perceived effectiveness, safety and financial cost.

Results: Questionnaires were distributed to 350 patients, with 200 assessable replies received. Overall, 49% of patients in this group used CAM, with vitamins, antioxidants, alternative diets, and herbal therapies the most commonly used agents and usage was more common in younger patients. CAM was used by 47% to improve quality of life and by 30% in the hope of a cure of their cancer. Of CAM users, 71% believed these therapies had been helpful in the management of their cancer, and 89% felt they were safe. Only 41% of users had discussed CAM with their oncologist and almost one third had started such therapies before being seen at the Cancer Treatment Centre. The median cost of CAM was NZ$55/month.

Conclusions: CAM is commonly used by New Zealand cancer patients, who often use multiple therapies, not only during conventional treatment, but also without consultation with their oncologist. This lack of open communication about CAM between patients and medical staff may prevent identification not only of potential harmful effects, but also of positive and negative drug interactions between CAM and conventional therapies.

Citing Articles

Exploring Integrative Approaches: Insights Into Complementary Medicine Practices Among Breast Cancer Survivors in Saudi Arabia.

Abusanad A, Ujaimi R, Alotaibi M, Alharbi L, Alatawi N, Algarni A Cureus. 2024; 16(1):e52282.

PMID: 38357079 PMC: 10865160. DOI: 10.7759/cureus.52282.


The prevalence and pattern of complementary and alternative medicine use among cancer patients in a tertiary oncology center: a cross-sectional study.

Almouaalamy N, Banjar L, Alshaikh H, Altowairqi J, Alharbi N, Alghamdi W Ann Med Surg (Lond). 2023; 85(11):5420-5427.

PMID: 37915654 PMC: 10617909. DOI: 10.1097/MS9.0000000000001315.


How cancer patients get fake cancer information: From TV to YouTube, a qualitative study focusing on fenbendazole scandle.

Kim J, Oh K, Shin H, Jun J Front Oncol. 2022; 12:942045.

PMID: 36387110 PMC: 9650234. DOI: 10.3389/fonc.2022.942045.


Patient activation, self-efficacy and usage of complementary and alternative medicine in cancer patients.

Hubner J, Welter S, Ciarlo G, Kasmann L, Ahmadi E, Keinki C Med Oncol. 2022; 39(12):192.

PMID: 36071252 PMC: 9452424. DOI: 10.1007/s12032-022-01796-8.


An exploration of barriers and enablers to the conduct and application of research among complementary and alternative medicine stakeholders in Australia and New Zealand: A qualitative descriptive study.

Veziari Y, Kumar S, Leach M PLoS One. 2022; 17(2):e0264221.

PMID: 35180276 PMC: 8856519. DOI: 10.1371/journal.pone.0264221.